Breaking News:
Become a member
Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click. Combine them, rearrange them and customize them further as much as you desire.
All Latest Articles
Clinical Trial Explores Psychedelic Treatment for Depression
LOS ANGELES- In a move within the field of psychiatric treatment, MindBio Therapeutics Corp. has announced the launch of its Phase 2B clinical trial,...
Indiana’s Pioneering Psilocybin Research Bill Awaits Governor’s Approval
LOS ANGELES- In a groundbreaking legislative move, Indiana stands on the precipice of advancing psilocybin research, following the final approval of a bill aimed...
Cybin Eyes $150 Million Boost Through Private Placement to Propel Psychedelic Drug Development
Cybin Inc., a firm at the forefront of psychedelic drug development, announced its plan on Wednesday to secure approximately $150 million in funding through...
atai Life Sciences Advances VLS-01, A Novel DMT-Based Treatment
LOS ANGELES- atai Life Sciences a biotechnology company specializing in mental health treatments, is making strides in the development of a groundbreaking approach to...
FDA’s ‘Breakthrough’ Nod to MM120, An LSD-Derivative, for Anxiety Relief
LOS ANGELES- In a significant development within the field of psychedelic therapy, the Food and Drug Administration (FDA) has recognized the LSD-analog substance MM120,...
New Mexico Advances Psilocybin Research with Memorial Legislation
-LOS ANGELES- In a significant move toward exploring alternative therapeutic treatments, New Mexico Governor Michelle Lujan Grisham has signed Senate Memorial 12 (SM-12), initiating...
